Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-08-28

Clinical Trial Update: Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy Subjects [NA]

View source ↗

Summary

A clinical trial update from the University of Bologna examining different dosages of bioactive wheat peptides and their effects on blood pressure and cardiovas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bioactive Wheat Peptides (bioactive wheat peptides)

Snippet

Sponsor: University of Bologna | Conditions: Pre-hypertension | NA | Status: UNKNOWN